tirzepatide heart failure trial for with Preserved Ejection Fraction and Obesity Tirzepatide Reduces Heart Failure Events

See the end of this Medication Guide for a complete list of ingredients in WEGOVY injection and WEGOVY tablets

[DOI] [PMC free article] [PubMed] [Google Scholar] 4.Murray KF, Hadzic N, Wirth S, Bassett M, Kelly D

Zepbound (tirzepatide) is a prescription medication approved by the FDA in November 2023 for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition

Many clients notice improved energy, focus, and wellness within 24 to 48 hours, though results vary by individual and vitamin status

GLP-1 receptor agonists act downstream, targeting the visceral fat accumulation, insulin resistance, and dysregulated appetite that estrogen's absence creates

NCCIH (National Center for Complementary and Integrative Health) - publishes evidence summaries on weight management approaches and how they compare to prescription medication options